Company Encyclopedia
View More
name
Fresh Tracks Therapeutics
FRTX.US
Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc.
1.925 T
FRTX.USMarket value -Rank by Market Cap -/-

Financial Score

30/12/2025 Update
B
BiotechnologyIndustry
Industry Ranking0/401
Industry medianC
Industry averageD
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-66.50%E
    • Profit Margin-71.12%E
    • Gross Margin60.25%A
  • Growth ScoreB
    • Revenue YoY15.31%B
    • Net Profit YoY73.02%A
    • Total Assets YoY12.80%B
    • Net Assets YoY38.03%A
  • Cash ScoreC
    • Cash Flow Margin-140.60%D
    • OCF YoY15.31%B
  • Operating ScoreB
    • Turnover0.73B
  • Debt ScoreA
    • Gearing Ratio14.29%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Fresh Tracks Therapeutics (OTC Pink: FRTX) dissolves, distributes cash to stockholders, terminates trading.

    A company based in Boulder, Colorado, Fresh Tracks Therapeutics, Inc. (OTC Pink: FRTX), provided an update regarding its intended dissolution on February 25, 2025. The company, also known as Fresh Tracks, outlined its procedures for distributing cash to shareholders as part of this dissolution plan.

    Unusual Whales·
    US
    FRTX
    0.00%
    Unusual Whales·
    US
    FRTX
    0.00%

    Fresh Tracks Therapeutics to distribute assets as per court ruling. Delaware Court of Chancery approved the consent judgment.

    Today, Fresh Tracks Therapeutics, Inc. (OTC Pink: FRTX) made an announcement in Boulder, Colorado on January 27, 2025, revealing that the Court of Chancery in Delaware approved the consent judgment in the case involving David. The Company avoided further legal proceedings by reaching this agreement.

    Unusual Whales·
    US
    FRTX
    0.00%
    Unusual Whales·
    US
    FRTX
    0.00%
    © 2025 Longbridge｜Disclaimer